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Summary Gradient-recalled echo magnetic resonance imaging (GRE MRI), which gives information on blood flow and oxygenation changes
(Robinson SP, Howe FA, Griffiths JR 1995, Int J Radiat Oncol Biol Phys 33: 855), was used to observe the responses of six rodent tumour
models to carbogen breathing. In one transplanted rat tumour, the Morris hepatoma 9618a, and a chemically induced rat tumour, the MNU-
induced mammary adenocarcinoma, there were marked image intensity increases, similar to those previously observed in the rat GH3
prolactinoma. In contrast, the rat Walker carcinosarcoma showed no response. In two mouse tumours, the RIF-1 fibrosarcoma and the human
xenograft HT29, carbogen breathing induced a transient fall in signal intensity that reversed spontaneously within a few minutes. The rat GH3
prolactinoma was xenografted into nude mice, and an increase in image intensity was found in response to carbogen, suggesting that any
effects that carbogen may have had on the host were not significant determinants of the tumour response. The increases in GRE image
intensity of the MNU, H9618a and GH3 tumours during carbogen breathing are consistent with increases in tumour oxygenation and blood
flow, whereas the responses of the RIF-1 and HT29 tumours may be the result of a transient steal effect followed by homeostatic correction.
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Tumour blood flow and oxygenation are critical determinants of
many forms ofcancertherapy. Poorly perfused regions oftumours
are hypoxic and hence resistant to radiotherapy. Radioresistance
caused by hypoxia is thought to develop by two mechanisms:
diffusion-limited orchronic hypoxia, due to reduced oxygen diffu-
sion to regions distant from the tumour blood vessels (Thomlinson
and Gray, 1955) and acute hypoxia caused by transient occlusion
of vessels (Chaplin et al, 1986). Several approaches have focused
on improving tumour blood flow and oxygenation for therapeutic
advantage. One such strategy is carbogen (95% oxygen, 5%
carbon dioxide) breathing, an adjuvant therapy that enhances
rodent tumour radiosensitivity (Song et al, 1987; Chaplin et al,
1991; Kjellen et al, 1991). Furthermore, carbogen, in combination
with nicotinamide, an agent thought to target acutely hypoxic
regions (Chaplin et al, 1991), is currently undergoing clinical trials
as a radiosensitizer (Rojas, 1992).
Currently, there is no satisfactory non-invasive method for
monitoring tumour oxygenation (McCoy et al, 1996). A meta-
analysis of 83 radiosensitization trials, totalling 10 073 patients,
showed significant improvements in local control and survival,
implying that hypoxia causes radiation failure in some but not all
tumours (Overgaard, 1995). A non-invasive technique that could
be used to assess changes in oxygenation and perfusion, and their
heterogeneous distribution within the whole tumour, would thus
be ofconsiderable clinical value.
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Gradient-recalled echo (GRE) magnetic resonance imaging
(MRI) methods have been used to observe spatial and temporal
changes in cerebral oxygenation and/or blood flow in response to
an external stimulus (Ogawa et al, 1990; Kwong et al, 1992;
Rostrup et al, 1994). Images are usually acquired using GRE
sequences that are sensitive to changes in the nuclear magnetic
resonance (NMR) relaxation time T2*, the time constant for the
decay of transverse magnetization. T2* decay is the combined
effect of irreversible spin-spin dephasing (T2) and reversible
dephasing due to magnetic field inhomogeneities. Deoxyhaemo-
globin, which is paramagnetic, creates large magnetic suscepti-
bility variations in the proximity of blood vessels, and these
generate additional phase dispersion of water proton signals,
shortening T2*. In T2*-weighted images, image pixels of tissues
with large magnetic susceptibility gradients, i.e. regions near
deoxygenated veins and capillaries, appear dark. GRE images of
tumours can be used to monitor changes in the concentration of
deoxyhaemoglobin, whether as a result ofblood flow modification
or of the fractional desaturation of oxygen from the blood.
Deoxyhaemoglobin thus acts as an endogenous contrast agent.
Oxygen itselfis also paramagnetic, so changes in dissolvedplasma
oxygen tension may also contribute to image contrast (Berkowitz,
1996). GRE images are also sensitive to the so-called 'in-flow
effect' (Duyn et al, 1992). The water in fresh blood flowing into
the selected imaging slice is not subject to saturation from the
previous radiofrequency pulse, so it produces a stronger signal
than that from static water in tissue. An increase in tumour blood
flow could thus result in an increase in GRE signal.
We initially demonstrated the applicability ofGRE imaging to the
study of tumour physiology by showing that carbogen breathing
induced dramatic increases of up to 100% in image intensity of
transplanted GH3 prolactinomas (Robinson et al, 1995) and we
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Table 1 Mean tumour volume + s.d. for each line used in this study
Tumour Volume (cm3)
MNU mammary carcinoma 1.5 ± 0.3
H9618a hepatoma 2.1 ± 0.4
Walker carcinosarcoma 1.7 + 0.7
RIF-1 fibrosarcoma 0.78 ± 0.2
HT29 colon carcinoma 0.86 ± 0.1
GH3 prolactinoma 0.98 ± 0.2
suggested that this response was a consequence of an improvement
in both tumour oxygenation and blood flow. An increase in tumour
blood flow results in less desaturation of the blood oxygen, less
deoxyhaemoglobin and, hence, a more intense GRE signal. In later
studies, we measured T2* and flow contributions to image intensity
contrast changes during carbogen breathing in order to discriminate
between tumour oxygenation and blood flow changes (Howe et al,
1995). Tumour T2* was very heterogeneous, even in air-breathing
animals, with large localized increases of up to 75% during
carbogen breathing. Calculated flow maps also showed considerable
heterogeneity, and regions of maximum increase in flow did not
always coincide with maximum increases in T2*. An increase in the
uptake ofthe freely diffusible tracer, 2H20, in response to carbogen
breathing was observedby2H-MRL[4RS, giving directevidence for
a relative increase in tumour blood flow in response to carbogen
(Robinson et al, 1996). Thus, we have described these changes in
GRE images of tumours as FLOOD (flow and oxygenation depen-
dent) contrast (Howe et al, 1996).
Hitherto, the increase in GRE image intensity in response to
carbogen breathing has only been demonstrated in a transplanted
rat tumour model, the GH3 prolactinoma (Robinson et al, 1995).
We now report the response to carbogen breathing, observed by
GRE MRI, of six other tumour types and discuss these observa-
tions with respect to tumour physiology.
MATERIALS AND METHODS
Primary mammary carcinomas were induced in female Ludwig
Wistar rats by three injections (50 mg kg-') of N-methyl-N-
nitrosourea (MNU) (Williams et al, 1981). The tumours grew up in
various sites associated with the mammary tissue. IWo non-
immunogenic, well-established transplantable rat tumours were
also used, the Morris hepatoma 9618a implanted subcutaneously
in the flanks of Buffalo rats and the Walker carcinosarcoma
implanted subcutaneously in the flanks of female Wistar rats
(Stubbs et al, 1989a,b). Three transplanted murine tumour models
were used, the RIF-I fibrosarcoma grown in the flanks of C3H
mice (Twentyman et al, 1980), the HT29 colon carcinoma, a human
xenograft grown in the flanks ofnulnu mice (Kimball and Brattain,
1980) and the rat GH3 prolactinoma also grown in nulnu mice.
To immobilize the animal during MRI, anaesthesia was induced
with a single intraperitoneal (i.p.) injection of a combination of
fentanyl citrate (0.315 mg ml-') plus fluanisone (10 mg ml-')
(Hypnorm; Janssen Pharmaceutical Ltd), midazolam (5 mg ml-')
(Hypnovel; Roche) and water (1:1:2), at a dose of4 ml kg-' for the
rats and 10 ml kg-1 for the mice. This anaesthetic mixture has been
shown to have a minimal effect on tumour blood flow (Menke and
Vaupel, 1988) and 3'P-MRS characteristics (Sansom and Wood,
1994). The mean tumour volume for each line used in this study is
shown in Table 1. The animals were placed on a flask containing
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Figure 1 GRE images obtained from one MNU-induced mammary
carcinoma (A) before and (B) during carbogen breathing, and one Morris
hepatoma 9618A (C) before and (D) during carbogen breathing. The images
correspond to the midpoints of the air and carbogen episodes. See text for
acquisition parameters
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Figure 2 Variation in normalized image intensity of (A) MNU-induced
mammary carcinomas (n = 4) and (B) Morris hepatomas 961 8a (n = 5) with
time. Carbogen or air was administered at 2 min-'. The shaded area
corresponds to the episode of carbogen breathing
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Figure 3 GRE images obtained from a RIF-1 fibrosarcoma and HT29 colon
carcinoma (A and D) before, (B and E) 4 min into and (C and F) 14 min into
breathing carbogen. See text for acquisition parameters
recirculating warm water to maintain the core temperature at 37°C
and positioned so the tumour hung vertically into a single-turn 2-
cm coil (rat) or a 1.2-cm coil (mouse). Carbogen or air was admin-
istered via a nose-piece, equipped with a scavenger.
MRI was performed with a Spectroscopy Imaging Systems
Corporation (SISCO, Varian NMR Instruments, Palo Alto CA,
USA) 4.7-tesla, 33-cm bore system, equipped with a 10 g cm-'
high-performance gradient insert. For the GRE imaging sequence,
an echo time (TE) of 20 ms, repetition time (TR) of 80 ms and flip
angle (a) of45° were used. A 1-mm (rat) or 0.5-mm (mouse) slice
through the centre ofthe tumour was chosen and eight acquisitions
of 256 phase encode steps over a 4-cm field of view were used.
After zero-filling to a 512 matrix, the in-plane resolution was 0.08
mm by 0.08 mm. Each image took 4 min to acquire.
Baseline images were initially acquired while air was adminis-
tered at 2 1 min-'. Carbogen was then administered at 2 1 min-
and subsequent images acquired. The average pixel intensity was
calculated over a region of interest (ROI) that encompassed the
tumour but excluded the skin. The average pixel intensity in the
ROI during air breathing was set to 100%. To test the efficiency of
the scavenger in removing non-inspired or exhaled carbogen from
the bore of the magnet, GRE MRI was performed, as described
above, on three dead mice bearing HT29 tumours.
Rat and mouse arterial blood pO2 was determined from arterial
blood gas analysis of samples taken from separate cohorts of
tumour-bearing animals while breathing either air or carbogen.
Mean arterial blood pressure was also measured in rats using a rat
tail blood pressure monitor (Harvard Apparatus, Edenbridge).
RESULTS
Figure 1 shows GRE images obtained from an MNU-induced
mammary carcinoma (A) before and (B) during carbogen breathing.
Tumour images during air breathing were heterogeneous, with
regions ofintense signal and others oflittle or no signal. Within the
high-intensity regions were structures that might be blood vessels.
The heterogeneity ofthe GRE MRI signals became further accentu-
ated during carbogen breathing. Regions with little or no signal did
not enhance during carbogen breathing and probably correspond to
areas of poor perfusion or necrosis. Figure 2A depicts the 20-40%
increase in normalized image intensity seen in the MNU-induced
tumours (n = 4) in response to carbogen.
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Figure 4 Variation in normalized image intensity of (A) RIF-1 fibrosarcomas
(n = 7) and (B) HT29 colon carcinomas (n = 4) with time. Carbogen or air
was administered at 21 min-'. The shaded area corresponds to the episode
of carbogen breathing
The transplanted Morris hepatoma 9618a showed a dramatic
response to carbogen, similar in magnitude to that seen and
reported earlier with the GH3 tumours (Robinson et al, 1995).
Images obtained from one tumour before and during carbogen
breathing are shown in Figure IC and D. Increases of over 100%
in normalized image intensity over the whole tumour were
observed (n = 5), as shown in Figure 2B. In contrast, no response
to carbogen breathing was observed in the Walker carcinosarcoma
(n = 4, images not shown).
Figure 3 shows GRE images acquired from a RIF-1 fibosarcoma
(A-C) and an HT29 colon carcinoma (D-F) before, 4 min into and
14 min into breathing carbogen. The images were more homoge-
neous than those acquired from the rat tumours, both during air
and carbogen breathing. Figure 4 depicts the changes in normal-
ized image intensity seen in RIF-l tumours (n = 7) and HT29
xenografts (n =4) in response to carbogen. A transient decrease in
image intensity over the whole tumour was consistently observed
in all RIF-1 tumours (8% to 27%) and three out of four HT29
xenografts (6% to 15%) upon switching the gas supply from air to
carbogen, with a subsequent recovery back to baseline image
intensity levels within 10 min, even though the animal continued
to breathe carbogen.
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Figure 5 Variation in normalized image intensity of (A) sacrificed HT29 colon
carcinomas (n = 3) and (B) GH3 prolactinomas grown in nu/nu mice (n = 4)
with time. Carbogen or air was administered at 2 min-'. The shaded area
corresponds to the episode of carbogen breathing
Leakage of paramagnetic oxygen into the magnet bore would
change the magnetic susceptibility around the coil (Bates et al,
1995) and produce a small Bo shift around the tumour. To mini-
mize this effect (which could produce spurious image intensity
changes), a scavenger was used routinely around the nose-piece
that administered the gases. Since the increase in signal intensity
was more common in rat than in mouse tumours, we considered
the possibility that in mice the close anatomical proximity of the
tumour and, hence, the radiofrequency coil to the nose-piece could
have resulted in a change in magnetic susceptibility. However,
experiments using HT29 tumours in dead mice (n = 3) demon-
strated no change in the normalized GRE image intensity of the
tumour on switching from air to carbogen (Figure 5A). This
implies that the transient signal decrease seen in the tumours is
dependent on vital processes and not a consequence of a change in
magnetic susceptibility induced by oxygen in the magnet bore.
To investigate further the apparent differences between the rat
and mouse responses, the GH3 prolactinoma was transplanted into
nude mice to look at the effect ofthe host species on the carbogen-
induced tumour response. Large increases in normalized image
intensity of up to 120% were observed in response to carbogen (n
= 4), shown in Figure 5B. GRE images acquired from one mouse
Figure 6 GRE images obtained from one GH3 prolactinoma grown in a
nu/nu mouse (A) before and (B) during carbogen breathing. The images
correspond to the midpoints of the air and carbogen episodes. See text for
acquisition parameters
Table 2 Changes in mouse and rat arterial blood oxygenation (P1O2) and rat
mean arterial blood pressure (MABP) in response to carbogen breathing
(mmHg)
Air Carbogen (2 min) Carbogen (10 min)
Mouse blood PaO2 106±9 531 ±5** 574±60**
Rat blood PaO2 115 ± 12 240 ± 40* 274 ± 50*
RatMABP 98±8 102±5 99±6
n = 5, mean ± sem. **P< 0.01;* P< 0.05, Student's t-test.
GH3 tumour before and during carbogen breathing are shown in
Figure 6.
Both mouse and rat arterial bloodpO2 increased significantly in
response to carbogen after 2 min breathing carbogen to levels that
were sustained for at least 10 min (Table 2). No significant change
(P > 0.1) in rat mean arterial blood pressure was observed in
response to carbogen breathing over the same time period.
DISCUSSION
The large increases in GRE image intensity observed in the
primary MNU-induced mammary carcinomas, transplanted
Morris hepatomas 9618a and GH3 prolactinomas grown in nude
mice were qualitatively similar to those previously reported in rat
GH3 prolactinomas during carbogen breathing (Robinson et al,
1995). The changes in signal intensity within the air and carbogen
breathing episodes were negligible compared with the changes
observed when switching from air to carbogen breathing. Our
original data showed no significant changes in GRE signal inten-
sity over a period of 1 h air breathing, suggesting that anaesthesia
had no effect. In addition, we and others (Brizel et al, 1995) have
shown that carbogen breathing has no effect on mean arterial
blood pressure in rats, which implies that the observed changes in
GRE image intensity are most likely a result of improved
oxygenation ofthe blood.
The carbogen-induced increase in GRE image intensity is
consistent with an improvement in tumour blood oxygenation that
reduces the concentration of deoxyhaemoglobin in the venous
blood. Carbogen breathing could improve tumour blood oxygena-
tion in two ways: (1) the 95% oxygen could simply increase the
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arterial bloodpO2; (2) the 5% carbon dioxide could induce vasodi-
lation of the afferent tumour vessels and thus increase tumour
blood flow,causing pooled,deoxygenated venous blood in tumour
sinusoids to be flushed out by fresh, oxygenated blood. Both
mechanisms would result in less desaturation ofthe blood oxygen,
less deoxyhaemoglobin and a more intense GRE signal. Our
results with rat GH3 prolactinomas suggest that both tumour
oxygenation and blood flow changes occur during carbogen
breathing (Howe etal, 1997).Preliminary studies with otherestab-
lished techniques show increases in blood flow (Robinson et al,
1996) and oxygen tension (DR Collingridge and SP Robinson,
unpublished results) in GH3 tumours while the rat is breathing
carbogen, consistent with the MR findings. Image intensity
increases in cortical and central grey matter have been observed
previously during inhalation of5% carbon dioxide, consistent with
an increase in cerebral perfusion (Rostrup et al, 1994).
The increase in signal intensity on GRE imaging observed with
carbogen was first demonstrated in a transplanted rat tumour, the
GH3 prolactinoma grown in Wistar Furth rats (Robinson et al,
1995). Since transplanted tumours are usually initiated with an
injection ofthousands or millions ofcells, many of which begin to
grow simultaneously, the blood supply that they induce is very
chaotic (Falk, 1982) compared with spontaneous primary tumours,
which grow from a single transformed cell and develop a fairly
regular blood supply. The MNU-induced mammary carcinoma was
studied because it is similar to a spontaneous primary tumour, in
that it also grows from a single transformed cell and may therefore
beexpected to have a different response tocarbogen on the basis of
its vascularity. The response was about one-third ofthatpreviously
observed in GH3 prolactinomas, perhaps because it is more like a
true primary tumour than the transplants on which the rest of this
study were performed. The lack ofGRE MRI response tocarbogen
observed in the Walker 256 carcinosarcomas is as yet unexplained
but may be due to low vascular density in these tumours.
The transient decrease in GRE image intensity observed in the
RIF-1 fibrosarcomas and HT29 colon carcinomas implies a tran-
sient increase in deoxyhaemoglobin. This could result from a
decrease in tumour blood oxygenation and/or blood flow in these
tumour lines during the first 4 min of carbogen breathing, with a
subsequent spontaneous recovery to baseline levels, even though
the animal continues to breathe carbogen.
The transient decreases in GRE MRI signal intensity seen in the
RIF-1 and responding HT29 tumours were very variable: 8-27%
in the RIF-1 and 6-15% in the HT29. Notably, whatever the level
of transient decrease, the signal spontaneously returned to a level
very close to the baseline in every tumour. This reversion to the
baseline suggests that a homeostatic mechanism is responsible or
that the effect is inherently self-limiting. Three hypotheses could
be put forward to account for the initial decrease in GRE signal
intensity: a decrease in the oxygen content ofthe blood; a decrease
in tumour blood flow; or an 'intratumoral steal effect', i.e. an
increase in blood flow in some parts of a tumour that steals blood
from other parts (Karczmar et al, 1995). Intratumoral steal is
unlikely as it would require both localized increases and decreases
in deoxyhaemoglobin in different parts of the RIF-1 and HT29
tumours, whereas the GRE images of these tumours were
extremely homogeneous during both air and carbogen breathing.
Mouse arterial blood pO2 dramatically increased in response to
carbogen (Table 2), which seems to eliminate the first hypothesis,
so a decrease in tumourperfusion is the most likelyexplanation for
the initial reduction in signal intensity.
An obvious explanation for the different tumour responses
could be that the nature of the host animal species affects the
response of the tumours to carbogen, since the transient decrease
in signal intensity was observed in two murine tumour models,
whereas increases have been found in three of the four rat models
studied. Mouse haemoglobin is only about 75% saturated with
oxygen at pO2 levels prevailing in the lungs (approximately 100
mmHg), while rat haemoglobin, like human haemoglobin, is more
saturated (Gray and Steadman, 1964). This is one reason why the
mouse is thought to be a poor model for preclinical studies of
tumour oxygenators (Calais and Hirst, 1991). Because of this
difference in haemoglobin saturation, the large increase in mouse
arterial bloodpO2 in response to carbogen would have resulted in a
greater increase in oxygen supply to mouse tumours than to rat
tumours [in which similar bloodpO2 levels have been found by us
and others (Brizel et al, 1995)], and hence an increase in GRE
image intensity might have been anticipated.
In order to distinguish the effects resulting from the rodent host
species from those caused by the tumour type, rat GH3
prolactinoma cells were transplanted into nude mice and the
responses of the resulting tumours to carbogen were measured
(Figure 5B). The responses were very similar to those observed in
GH3 tumours grown in rats (Robinson et al, 1995). This suggests
that the different RIF-1 and HT29 responses may reflect a property
ofthe tumours themselves, rather than the host species. We earlier
advanced the hypothesis that the transient decreases in GRE signal
intensity observed in these two mouse-borne tumours in response
to carbogen were caused by transient host vasodilation inducing a
steal effect. GH3 tumours in nude mice do not show a transient
decrease in GRE signal intensity, suggesting that, if a transient
steal effect occurs, it cannot be observed in tumours that respond
strongly to carbogen.
If the initial change in GRE signal intensity is indeed caused by
a change in tumour blood perfusion, then it is likely that the spon-
taneous correction also results from a blood vascular mechanism.
In principle, these effects could occur either in the host blood
vessels or those ofthe tumour, or both. Ifthe host vascular system
is responsible, it would involve a 'steal' effect in which carbogen
causes a brief period of host vasodilation and hence hypotension,
analogous to (but briefer than) the effect of hydralazine (Field et
al, 1991; Wood et al, 1992). If the tumour blood vessels fail to
dilate, because they have no receptors or vasoactive mechanism,
then the tumour blood flow will fall. We are currently unable to
measure mouse blood pressure, so we cannot test this hypothesis
directly.
If, on the other hand, the transient GRE effect is caused by the
tumour vasculature, it implies that carbogen causes a transient
decrease in perfusion of these tumours, perhaps because the
oxygen-induced vasoconstriction is greater than the carbon dioxide
induced vasodilation. This hypothesis would also require that the
effect be self-correcting, either because it induces a countervailing
homeostatic mechanism orbecause it is inherently transient.
Both these mechanisms would have to take account ofthe well-
known radiosensitizing effect of carbogen (Song et al, 1987) and
of a recent report (Honess and Bleehen, 1995) that carbogen
breathing causes an increase in RIF-l tumour blood flow. A fall in
tumour blood flow lasting a few minutes would be unlikely to
affect radiosensitivity unless the radiation were administered in
that time window. Perhaps carbogen improves oxygenation and
hence radiosensitivity without significantly decreasing tumour
deoxyhaemoglobin. Honess and Bleehen (1995) administered
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carbogen in a different way to us and at lower flow rates than
the one we used (2 1 min-'). At flow rates of 50-200 ml min-',
they observed significant blood flow increases (as t6Rb uptake),
but the increases were smaller and statistically insignificant at
300 ml min-', the highest rate they used. One possible explanation
for the apparent discrepancy between our results and theirs is that
the sixfold higher flow rate we used suppressed the effect. Another
possibility is that there is an increase in blood flow but no signifi-
cant decrease in deoxyhaemoglobin.
If we accept that transient host vasodilation in response to
carbogen caused the transient decrease in GRE signal in the RIF-1
and HT29 tumours, why was this effect not seen in the GH3
prolactinomas, MNU-induced rat mammary carcinomas or the
Morris hepatoma 9618a? In all these cases there was a marked
increase in GRE signal intensity that was constant until air
breathing was resumed. One possible explanation is that massive
vasodilation occurred in these tumours and thus 'steal' by the host
vasculature did not occur. In this context, it should also be remem-
bered that the overall GRE signal intensity may not be directly
related to the overall oxygenation state of the tumour. Some
tumours may contain blood vessels, such as venous sinusoids, that
contain large amounts of very slow-flowing blood and thus high
levels of deoxyhaemoglobin. Carbogen-induced dilation of
smooth muscle in the arterioles supplying these sinusoids could
result in a massive rise in GRE signal that might outweigh any
transient fall induced by host vasodilation.
In summary, the most likely explanation for the differing GRE
MRI responses observed in this study is the different vascular
architecture that exists within each tumour type. These differences
re-emphasize the importance oftumour model selection for cancer
research. From a clinical standpoint, it is encouraging that the
response to carbogen is observable in a primary tumour model
(MNU-induced mammary adenocarcinoma) that arises from a
single transformed cell. Significant increases in median pO2,
measured by microelectrodes, in response to carbogen have been
reported for a range of human tumours (Falk et al, 1992; Laurence
et al, 1995) and data on 19 patients indicate that responses of
human tumours to carbogen breathing can be satisfactorily moni-
tored by GRE MRI (Taylor et al, 1996). This method may thus
become a useful clinical tool in the assessment ofpatient treatment
protocols by monitoring tumour blood flow and oxygenation non-
invasively.
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